Literature DB >> 5412843

Genesis of ascites in ovarian cancer.

K Hirabayashi, J Graham.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1970        PMID: 5412843     DOI: 10.1016/0002-9378(70)90031-1

Source DB:  PubMed          Journal:  Am J Obstet Gynecol        ISSN: 0002-9378            Impact factor:   8.661


× No keyword cloud information.
  12 in total

1.  Leukokinins; their pharmacological properties and role in the pathology of fluid (ascites) accumulation.

Authors:  L M Greenbaum; G Semente; A Prakash; S Roffman
Journal:  Agents Actions       Date:  1978-01

2.  Intraperitoneally administered 90Y-labelled monoclonal antibodies as a third line of treatment in ovarian cancer. A phase 1-2 trial: problems encountered and possible solutions.

Authors:  V Hird; J S Stewart; D Snook; B Dhokia; C Coulter; H E Lambert; W P Mason; W P Soutter; A A Epenetos
Journal:  Br J Cancer Suppl       Date:  1990-07

3.  Hyaluronidase activity in gynaecological cancer tissues with different metastatic forms.

Authors:  K Tamakoshi; F Kikkawa; O Maeda; N Suganuma; S Yamagata; T Yamagata; Y Tomoda
Journal:  Br J Cancer       Date:  1997       Impact factor: 7.640

Review 4.  Meeting the challenge of ascites in ovarian cancer: new avenues for therapy and research.

Authors:  Emma Kipps; David S P Tan; Stan B Kaye
Journal:  Nat Rev Cancer       Date:  2013-02-21       Impact factor: 60.716

5.  In vitro degradation of extracellular matrix by human ovarian carcinoma cells.

Authors:  M J Niedbala; K Crickard; R J Bernacki
Journal:  Clin Exp Metastasis       Date:  1987 Apr-Jun       Impact factor: 5.150

6.  Pathogenesis of ascites in a murine transplantable reticulosarcoma type A.

Authors:  Z Pavelic; M Boranic; K Pavelic; M Vasarevic
Journal:  Z Krebsforsch Klin Onkol Cancer Res Clin Oncol       Date:  1976-12-20

7.  Epithelial-mesenchymal transition in ovarian carcinoma.

Authors:  Ben Davidson; Claes G Tropé; Reuven Reich
Journal:  Front Oncol       Date:  2012-04-10       Impact factor: 6.244

Review 8.  Significance of vascular endothelial growth factor in growth and peritoneal dissemination of ovarian cancer.

Authors:  Samar Masoumi Moghaddam; Afshin Amini; David L Morris; Mohammad H Pourgholami
Journal:  Cancer Metastasis Rev       Date:  2012-06       Impact factor: 9.264

9.  Ascites induces modulation of alpha6beta1 integrin and urokinase plasminogen activator receptor expression and associated functions in ovarian carcinoma.

Authors:  N Ahmed; C Riley; K Oliva; G Rice; M Quinn
Journal:  Br J Cancer       Date:  2005-04-25       Impact factor: 7.640

10.  Does VEGF facilitate local tumor growth and spread into the abdominal cavity by suppressing endothelial cell adhesion, thus increasing vascular peritoneal permeability followed by ascites production in ovarian cancer?

Authors:  Inga Bekes; Thomas W P Friedl; Tanja Köhler; Volker Möbus; Wolfgang Janni; Achim Wöckel; Christine Wulff
Journal:  Mol Cancer       Date:  2016-02-12       Impact factor: 27.401

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.